Skip to main content

Regulatory grounding

Every claim points to a real FDA citation.

The Audit Simulator scores every record against a living corpus of FDA recalls, enforcement reports, MAUDE narratives, and CDRH warning letters. Drafts cite specific sub-clauses - because that is what inspectors expect.

What’s in the corpus

Four public FDA sources, refreshed on a cadence. Each row links back to the specific clauses inspectors cite.

  • FDA recalls

    openFDA recall enforcement feed

    Class I, II, and III recalls with firm response, root-cause classification, and citing CFR clauses.

  • Enforcement reports

    FDA enforcement-action records

    Enforcement actions tied to medical-device firms with the action, cited regulation, and resolution status.

  • MAUDE device events

    Manufacturer And User Facility Device Experience

    Adverse-event narratives with product codes and reporter classifications - the field-data layer.

  • Warning letters & 483s

    CDRH inspection outputs

    Warning letters and 483 observations parsed to link each finding to a specific 21 CFR sub-clause.

The regulations Deminn cites

Six regulations, indexed at the sub-clause level.

  • 21 CFR Part 820FDA

    Quality System Regulation

    The US QMS for medical devices. Design controls, CAPA, production, complaints, management responsibility.

    Sub-clauses indexed
    • §820.30Design controls
    • §820.100Corrective and preventive action
    • §820.198Complaint files
    • §820.50Purchasing controls
    What inspectors look for

    Generic Part 820 citations without the specific sub-clause are routinely flagged.

    How Deminn cites it

    Drafts cite the specific sub-clause (e.g. §820.100(a)(3)) with the verbatim clause text.

  • 21 CFR Part 803FDA

    Medical Device Reporting

    The MDR rule. Which adverse events must be reported, what the report contains, and when it must be filed.

    Sub-clauses indexed
    • §803.20How to report
    • §803.50Reportable events for manufacturers
    • §803.53Five-day reports
    • §803.56Supplemental reports
    What inspectors look for

    Late submissions and missing reportability rationale are the two most common Part 803 findings.

    How Deminn cites it

    Decisions cite the triggering clause and stamp the 30-day clock from the date of awareness.

  • 21 CFR Part 11FDA

    Electronic records, electronic signatures

    How electronic records and signatures count as the regulatory equivalent of paper.

    Sub-clauses indexed
    • §11.10Controls for closed systems
    • §11.50Signature manifestations
    • §11.70Signature / record linking
    • §11.200Electronic signature components
    What inspectors look for

    Inspectors test the link between record, signer, timestamp, and the audit trail behind them.

    How Deminn cites it

    Closure signatures require password reverify; audit trail is append-only with SHA-256 chain hashing.

  • 21 CFR Part 812FDA

    Investigational Device Exemption

    The IDE rule. Covers significant-risk and non-significant-risk studies, sponsor duties, and records.

    Sub-clauses indexed
    • §812.20Application
    • §812.46Monitoring investigations
    • §812.140Records
    • §812.150Reports
    What inspectors look for

    Sponsor monitoring lapses and protocol deviations are the most-cited IDE findings.

    How Deminn cites it

    Records and deviations link to the protocol revision they belong to, so the chain survives an amendment.

  • ISO 13485ISO

    Quality management systems for medical devices

    The international QMS standard. Recognised by FDA QMSR (2026), Health Canada, MDSAP, and EU notified bodies.

    Sub-clauses indexed
    • §5.6.2Management review inputs
    • §7.3Design and development
    • §8.2.2Complaint handling
    • §8.5.2Corrective action
    What inspectors look for

    Notified-body audits flag missing management-review inputs more than any other §5.6.2 issue.

    How Deminn cites it

    Review packets aggregate KPIs, complaint trends, MDRs, and CAPA aging into the §5.6.2 list automatically.

  • ISO 14971ISO

    Application of risk management to medical devices

    The risk-management standard. Hazard ID, risk estimation, evaluation, and control across the lifecycle.

    Sub-clauses indexed
    • §4.4Risk management plan
    • §5.4Hazard identification
    • §7Evaluation of overall residual risk
    • §10Production and post-production activities
    What inspectors look for

    Auditors check whether the risk file was updated when post-market data showed a new hazard.

    How Deminn cites it

    New PMS signals trigger a risk-file diff so hazard, risk, and residual-risk stay current with field data.

A generic Part 820 citation is what gets flagged. The specific sub-clause is what closes the gate.

Most AI tools cite “21 CFR 820” as a section label. That is exactly what inspectors flag. Deminn cites the specific sub-clause with the verbatim text - because the corpus tells us which patterns fail records on inspection.

Get drafts that an inspector would accept.

Pilots include a founder walkthrough of the corpus and the citation validator.